Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1990-6-11
|
pubmed:abstractText |
To determine the effect of pharmacologic modulation of alterations of peripheral blood T-cell subsets caused by antigen-induced bronchoconstriction, we administered albuterol immediately after antigen-induced bronchoconstriction in a double-blind to protocol to 12 atopic asthmatic subjects. We also administered cromolyn sodium before antigen to 7 of the same subjects. Peripheral blood T-cell subset composition (CD4, CD8, Ia) of a highly purified T-cell preparation was determined before, 24, 48, 72, and 168 h after bronchoconstriction. We found that placebo inhalation immediately after antigen-induced bronchoconstriction did not affect subsequent peripheral blood T-cell subset changes (decrease in CD4+ and increase in Ia+ T lymphocytes). In contrast, inhaled albuterol abolished these T-cell subset changes. Although cromolyn sodium significantly decreased the severity of antigen-induced bronchoconstriction, it did not affect T-cell subset composition changes at the dosage used. We conclude that albuterol can ablate T-cell subset changes associated with antigen-induced bronchoconstriction. Cromolyn sodium ameliorates bronchoconstriction, but has no affect on T-cell subset composition changes. This implies that T-cell changes and bronchoconstriction caused by antigen inhalation are mediated through different pathways.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0341-2040
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
168
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
69-78
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2110603-Administration, Inhalation,
pubmed-meshheading:2110603-Albuterol,
pubmed-meshheading:2110603-Antigens,
pubmed-meshheading:2110603-Asthma,
pubmed-meshheading:2110603-Bronchi,
pubmed-meshheading:2110603-Bronchial Provocation Tests,
pubmed-meshheading:2110603-Constriction, Pathologic,
pubmed-meshheading:2110603-Cromolyn Sodium,
pubmed-meshheading:2110603-Double-Blind Method,
pubmed-meshheading:2110603-Forced Expiratory Volume,
pubmed-meshheading:2110603-Humans,
pubmed-meshheading:2110603-Immunoglobulin E,
pubmed-meshheading:2110603-Leukocyte Count,
pubmed-meshheading:2110603-T-Lymphocytes
|
pubmed:year |
1990
|
pubmed:articleTitle |
Antigen-induced T-cell changes: modulation by pharmacologic agents.
|
pubmed:affiliation |
Department of Medicine, Case Western Reserve School of Medicine, Cleveland, Ohio.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|